Schmittel A - Search Results

1

A phase II study of bendamustine chemotherapy as second-line treatment in metastatic uveal melanoma.

Schmidt-Hieber M, Schmittel A, Thiel E, Keilholz U. Schmidt-Hieber M, et al. Among authors: schmittel a. Melanoma Res. 2004 Dec;14(6):439-42. doi: 10.1097/00008390-200412000-00001. Melanoma Res. 2004. PMID: 15577312 Clinical Trial.

2

A clinical phase I trial of gemcitabine and treosulfan in uveal melanoma and other solid tumours.

Keilholz U, Schuster R, Schmittel A, Bechrakis N, Siehl J, Foerster MH, Thiel E. Keilholz U, et al. Among authors: schmittel a. Eur J Cancer. 2004 Sep;40(14):2047-52. doi: 10.1016/j.ejca.2004.04.031. Eur J Cancer. 2004. PMID: 15341977 Clinical Trial.

3

Independent prognostic factors for distant metastases and survival in patients with primary uveal melanoma.

Schmittel A, Bechrakis NE, Martus P, Mutlu D, Scheibenbogen C, Bornfeld N, Foerster MH, Thiel E, Keilholz U. Schmittel A, et al. Eur J Cancer. 2004 Nov;40(16):2389-95. doi: 10.1016/j.ejca.2004.06.028. Eur J Cancer. 2004. PMID: 15519510

4

Phase II trial of cisplatin, gemcitabine and treosulfan in patients with metastatic uveal melanoma.

Schmittel A, Scheulen ME, Bechrakis NE, Strumberg D, Baumgart J, Bornfeld N, Foerster MH, Thiel E, Keilholz U. Schmittel A, et al. Melanoma Res. 2005 Jun;15(3):205-7. doi: 10.1097/00008390-200506000-00010. Melanoma Res. 2005. PMID: 15917703 Clinical Trial.

5

Ifosfamide/liposomal daunorubicin is a well tolerated and active first-line chemotherapy regimen in advanced soft tissue sarcoma: results of a phase II study.

Siehl JM, Thiel E, Schmittel A, Hütter G, Deckert PM, Szelényi H, Keilholz U. Siehl JM, et al. Among authors: schmittel a. Cancer. 2005 Aug 1;104(3):611-7. doi: 10.1002/cncr.21211. Cancer. 2005. PMID: 15968689 Free article. Clinical Trial.

6

A two-cohort phase II clinical trial of gemcitabine plus treosulfan in patients with metastatic uveal melanoma.

Schmittel A, Schuster R, Bechrakis NE, Siehl JM, Foerster MH, Thiel E, Keilholz U. Schmittel A, et al. Melanoma Res. 2005 Oct;15(5):447-51. doi: 10.1097/00008390-200510000-00014. Melanoma Res. 2005. PMID: 16179873 Clinical Trial.

7

Phase II trial of second-line bendamustine chemotherapy in relapsed small cell lung cancer patients.

Schmittel A, Knödler M, Hortig P, Schulze K, Thiel E, Keilholz U. Schmittel A, et al. Lung Cancer. 2007 Jan;55(1):109-13. doi: 10.1016/j.lungcan.2006.09.029. Epub 2006 Nov 13. Lung Cancer. 2007. PMID: 17097191 Clinical Trial.

8

Circulating tumor cells as prognostic factor for distant metastases and survival in patients with primary uveal melanoma.

Schuster R, Bechrakis NE, Stroux A, Busse A, Schmittel A, Scheibenbogen C, Thiel E, Foerster MH, Keilholz U. Schuster R, et al. Among authors: schmittel a. Clin Cancer Res. 2007 Feb 15;13(4):1171-8. doi: 10.1158/1078-0432.CCR-06-2329. Clin Cancer Res. 2007. PMID: 17317826

9

Sunitinib treatment for patients with advanced clear-cell renal-cell carcinoma after progression on sorafenib.

Zimmermann K, Schmittel A, Steiner U, Asemissen AM, Knoedler M, Thiel E, Miller K, Keilholz U. Zimmermann K, et al. Among authors: schmittel a. Oncology. 2009;76(5):350-4. doi: 10.1159/000209961. Epub 2009 Mar 24. Oncology. 2009. PMID: 19321976

10

Transarterial chemoembolization of liver metastases from uveal melanoma after failure of systemic therapy: toxicity and outcome.

Schuster R, Lindner M, Wacker F, Krössin M, Bechrakis N, Foerster MH, Thiel E, Keilholz U, Schmittel A. Schuster R, et al. Among authors: schmittel a. Melanoma Res. 2010 Jun;20(3):191-6. doi: 10.1097/CMR.0b013e328334c36e. Melanoma Res. 2010. PMID: 20335820

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

96 results

Search Page

Filters